PDS Biotechnology Corporation (PDSB)
EBITDA Growth
16.22%
TTM · Period ending:
PDSB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported16.22%period ending
Latest reported16.22%period ending
PDSB TTM EBITDA YoY % (-126.71% → 16.22%)
Year-over-year change
High-resolution chart · PNG
PDSB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 16.2192% | |
| 15.6683% | |
| 10.3044% | |
| 16.2399% | |
| 12.3726% | |
| 19.0337% | |
| 15.8032% | |
| 25.5468% | |
| 20.3967% | |
| 1.2996% | |
| 2.5636% | |
| -71.6055% | |
| -61.5115% | |
| -54.1054% | |
| -92.1139% | |
| -49.8817% | |
| -78.563% | |
| -93.1236% | |
| -44.4053% | |
| -24.751% | |
| 6.2835% | |
| 23.0265% | |
| -104.7284% | |
| -79.3347% | |
| -385.3286% | |
| -7,040.8336% | |
| 73.0428% | |
| 76.8318% | |
| 92.4556% | |
| 99.5729% | |
| 47.3602% | |
| 19.8589% | |
| -2.3526% | |
| -40.8853% | |
| -29.7742% | |
| -23.2409% | |
| -23.9817% | |
| -28.6829% | |
| -40.7531% | |
| -64.4652% | |
| -126.7084% |